GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Changzhou Qianhong Biopharma Co Ltd (SZSE:002550) » Definitions » PB Ratio

Changzhou Qianhong Biopharma Co (SZSE:002550) PB Ratio : 2.69 (As of Apr. 27, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Changzhou Qianhong Biopharma Co PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-04-27), Changzhou Qianhong Biopharma Co's share price is ¥5.19. Changzhou Qianhong Biopharma Co's Book Value per Share for the quarter that ended in Sep. 2023 was ¥1.93. Hence, Changzhou Qianhong Biopharma Co's PB Ratio of today is 2.69.

Good Sign:

Changzhou Qianhong Biopharma Co Ltd stock PB Ratio (=2.42) is close to 3-year low of 2.4

The historical rank and industry rank for Changzhou Qianhong Biopharma Co's PB Ratio or its related term are showing as below:

SZSE:002550' s PB Ratio Range Over the Past 10 Years
Min: 1.93   Med: 2.96   Max: 9.82
Current: 2.69

During the past 13 years, Changzhou Qianhong Biopharma Co's highest PB Ratio was 9.82. The lowest was 1.93. And the median was 2.96.

SZSE:002550's PB Ratio is ranked worse than
65.28% of 962 companies
in the Drug Manufacturers industry
Industry Median: 1.925 vs SZSE:002550: 2.69

During the past 12 months, Changzhou Qianhong Biopharma Co's average Book Value Per Share Growth Rate was 3.40% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 1.70% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -1.70% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 1.80% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Changzhou Qianhong Biopharma Co was 81.00% per year. The lowest was -5.60% per year. And the median was 5.10% per year.

Back to Basics: PB Ratio


Changzhou Qianhong Biopharma Co PB Ratio Historical Data

The historical data trend for Changzhou Qianhong Biopharma Co's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Changzhou Qianhong Biopharma Co PB Ratio Chart

Changzhou Qianhong Biopharma Co Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.92 2.51 2.62 2.91 3.27

Changzhou Qianhong Biopharma Co Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.98 3.27 3.01 2.77 2.71

Competitive Comparison of Changzhou Qianhong Biopharma Co's PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Changzhou Qianhong Biopharma Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Changzhou Qianhong Biopharma Co's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Changzhou Qianhong Biopharma Co's PB Ratio distribution charts can be found below:

* The bar in red indicates where Changzhou Qianhong Biopharma Co's PB Ratio falls into.



Changzhou Qianhong Biopharma Co PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Changzhou Qianhong Biopharma Co's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Sep. 2023)
=5.19/1.928
=2.69

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Changzhou Qianhong Biopharma Co  (SZSE:002550) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Changzhou Qianhong Biopharma Co PB Ratio Related Terms

Thank you for viewing the detailed overview of Changzhou Qianhong Biopharma Co's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Changzhou Qianhong Biopharma Co (SZSE:002550) Business Description

Traded in Other Exchanges
N/A
Address
Number 90 Changjiang Middle Road, Xinbei distract, Jiangsu Province, Changzhou, CHN, 213022
Changzhou Qianhong Biopharma Co Ltd engages in the research and development, production, and sale of biopharmaceutical products with the focus on polysaccharides and enzymes in China. The company provides various products, including heparin sodium, heparin calcium, enoxaparin sodium, nadroparin calcium, and dalteparin sodium for use as anticoagulants; pancreatin for use as a digestive agent; asparaginase for use as an antineoplastic agent; and kallidinogenase kallikrein and heparinoid.

Changzhou Qianhong Biopharma Co (SZSE:002550) Headlines

No Headlines